Roche virtual late-stage oncology pipeline update at ASCO 2024

Roche has hosted a virtual event on 31st May 2024.


Agenda
Introduction	Bruno Eschli, Head of Investor Relations
Oncology & Hematology – Products and late-stage pipeline	Charles Fuchs, SVP Global Head of Oncology and Hematology, Product Development
Q&A

Webinar Replay

Investors

Past IR Events

View more Events

Downloads

Presentation

PDF

Discover more

GovernanceAbout Roche

Our corporate governance principles focus on sustainable value creation and prescribe a culture that recognises standards of good corporate governance and policy of transparent communication.

Product Development PipelineSolutions

Discover our pipeline of Pharmaceutical and Diagnostics developments

Frequently asked questionsInvestors

We answer the Roche investors-related most frequently asked questions

Finance Information ToolInvestors

Access the finance information tool for the latest Roche financial data.